PMID 16297979
The medication's primary mechanisms of action include: Enhanced insulin secretion : Stimulates pancreatic beta cells to release insulin in response to elevated blood glucose Reduced glucagon release : Suppresses inappropriate glucagon secretion from pancreatic alpha cells Delayed gastric emptying : Slows food transit from the stomach, promoting satiety (though this effect may diminish over time) Central appetite regulation : Acts on brain centers to reduce hunger and food intake Improved metabolic function : Weight loss from tirzepatide contributes to improved insulin sensitivity Regarding water retention specifically, fluid retention is not listed as a characteristic adverse effect of tirzepatide in FDA prescribing information or major clinical trials
Adipose tissue, especially visceral fat, functions as an active endocrine organ
Barrett-Jolley, R., Nunn, N., Womack, M
What starting dose do you recommend
People who are anti-diet often have a fraught history with either body image, or food, or eating disorders, or all three